GI Health
|
March 20, 2025

Crohn's Disease: A Comprehensive Medical Insight

Medically Reviewed by
Updated On
March 26, 2025

Imagine constantly living with unpredictable abdominal pain, diarrhea, and fatigue—never knowing when the next flare-up will strike. This is the daily reality for individuals with Crohn's disease, a chronic condition that affects over 1.6 million people in the United States alone and millions more worldwide. 

The disease not only impacts physical health but also disrupts work, relationships, and overall quality of life. This article provides a comprehensive overview of Crohn’s disease, including its causes, symptoms, diagnostic approaches, treatment options, and global perspectives. 

[signup]

What is Crohn's Disease?

Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract. Unlike some other digestive disorders, Crohn’s is lifelong and often requires ongoing management.

Definition and Overview

Crohn’s disease is an immune-mediated condition where the body’s immune system reacts abnormally to the gastrointestinal tract, leading to chronic inflammation, ulcers, and scarring. The disease can also cause narrowing (strictures), fistulas, and abscess formation, affecting nutrient absorption and digestion.

History of Crohn’s Disease

First described in 1932 by Dr. Burrill Crohn, along with Drs. Leon Ginzburg and Gordon Oppenheimer, Crohn’s disease was initially thought to be a form of intestinal tuberculosis. Since then, research has greatly expanded our understanding, yet the exact cause remains unknown.

Epidemiology

  • Crohn's disease affects about 1 in 250 people in developed nations.
  • It is most common in North America and Europe, with increasing cases in Asia, Africa, and South America due to changing diets and environments.
  • The disease affects men and women equally, but symptoms may present differently.
  • It is more common in Caucasians, though rising rates in Asian and Middle Eastern populations suggest environmental triggers.

Causes of Crohn's Disease

The exact cause of Crohn’s disease remains unknown, but research suggests it results from a complex interplay of genetic predisposition, environmental triggers, and immune system dysfunction. While no single factor is solely responsible, these elements collectively contribute to the chronic inflammation characteristic of the disease.

Hereditary Links

Family history plays a significant role in Crohn’s disease, with 15-20% of patients having a close relative with inflammatory bowel disease (IBD). Specific gene mutations, particularly in the NOD2 gene, have been associated with Crohn’s disease. 

Environmental Triggers

Diet and Lifestyle

Diet does not directly cause Crohn’s disease, but certain dietary patterns may influence inflammation. 

  • Diets high in processed foods, refined sugars, and unhealthy fats are linked to gut microbiome imbalances, which could lead to disease onset. 
  • Low-fiber, high-fat Western diets appear to increase the risk of Crohn’s, whereas Mediterranean and plant-based diets may have protective effects.

Smoking and Pollution

Smoking doubles the risk of developing Crohn’s disease and worsens symptoms by increasing inflammation in the intestines. Additionally, air pollution and industrial chemicals have been linked to higher IBD rates, suggesting that environmental toxins may play a role in triggering immune dysfunction.

Immune System Dysfunction

Dysregulation of the immune system can contribute to Crohn's disease. 

Autoimmune Responses

Crohn’s disease is an immune-mediated condition, meaning the immune system mistakenly attacks the intestinal lining, leading to chronic inflammation. Unlike infections where the immune system fights off harmful bacteria, in Crohn’s, the immune system overreacts to normal gut bacteria, causing persistent damage.

Inflammatory Pathways

Inflammatory chemicals called cytokines—particularly tumor necrosis factor-alpha (TNF-α), interleukin-12 (IL-12), and interleukin-23 (IL-23)—play a key role in the immune response. These cytokines contribute to ongoing inflammation and are the targets of many biologic therapies used to treat Crohn’s disease.

Rare Causes and Associations

Infections

While no single infection causes Crohn’s, research suggests that certain bacteria, such as Mycobacterium avium subspecies paratuberculosis (MAP), may contribute to inflammation in genetically susceptible individuals. Some studies have also linked various viral infections to increased Crohn’s risk.

Other Medical Conditions

Crohn’s disease shares features with other autoimmune disorders, such as rheumatoid arthritis and psoriasis, suggesting overlapping immune system abnormalities. Some patients with Crohn’s may also have concurrent inflammatory conditions affecting the skin, eyes, or joints.

Symptoms of Crohn's Disease

Crohn’s disease symptoms range from mild to severe and can affect different parts of the digestive system. Many patients experience periods of remission followed by unpredictable flare-ups. Since the disease can impact more than just the intestines, some also experience systemic and extraintestinal symptoms.

Common Symptoms

Gastrointestinal Symptoms

  • Persistent diarrhea—often bloody or containing mucus.
  • Severe abdominal cramping and discomfort, especially after meals.
  • Unintentional weight loss due to malabsorption and reduced appetite.
  • Nausea and vomiting in cases of intestinal blockages.
  • Bloating
  • Colic-like abdominal pain that relieves after a bowel movement.

Systemic Symptoms

  • Fatigue and weakness caused by chronic inflammation.
  • Fever and night sweats in active disease phases.
  • Anemia from blood loss and malabsorption of iron and vitamin B12.

Rare and Atypical Symptoms

Extraintestinal Manifestations6

  • Joint pain and swelling (arthritis).
  • Skin disorders include erythema nodosum (red nodules) and pyoderma gangrenosum (ulcerative lesions).
  • Eye inflammation (uveitis), which can cause pain and light sensitivity.

Neurological Symptoms

Some individuals with Crohn’s disease experience brain fog, migraines, and nerve pain, which may be linked to neurological complications of the condition. These can include neuropathy, myelopathy, posterior reversible encephalopathy syndrome (PRES), and polyneuropathy.

Diagnosing Crohn's Disease

Crohn’s disease can be misdiagnosed due to overlapping symptoms with irritable bowel syndrome (IBS), celiac disease, and infections. An accurate diagnosis is essential.

Clinical Evaluation and History

A thorough medical history helps identify symptom patterns, family history, and risk factors. Healthcare providers will ask about the following:

  • Onset, duration, and severity of symptoms, such as diarrhea, abdominal pain, and weight loss.
  • Family history of Crohn’s or other autoimmune diseases, as genetics play a role in susceptibility.
  • Dietary habits and lifestyle factors, including smoking, medication use, and stress levels.

A physical examination may reveal:

  • Abdominal tenderness or mass, particularly in the lower right quadrant where Crohn’s commonly affects the intestines.
  • Mouth ulcers, perianal fistulas, or skin inflammation are common extraintestinal signs.

Blood Tests 

While blood tests alone cannot diagnose Crohn’s, they can reveal inflammation, nutritional deficiencies, and disease activity:

  • Inflammatory Markers:C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) 
  • Complete blood count (CBC): May show anemia (low red blood cells) or elevated white blood cells due to chronic inflammation.
  • Fecal calprotectin: Measures intestinal inflammation and helps distinguish between IBD and irritable bowel syndrome (IBS).
  • Liver function tests (LFTs): These are used to check for liver involvement or medication side effects.

Advanced Diagnostic Techniques

Imaging Studies

Crohn’s can affect any part of the gastrointestinal tract; imaging helps assess disease extent and complications:

  • Magnetic Resonance Enterography (MRE): Preferred imaging method for assessing Crohn’s disease.  Also useful for evaluating small bowel involvement and fistulas.
  • Computed Tomography (CT) Scan: Identifies intestinal wall thickening, abscesses, and bowel obstructions.
  • Ultrasound: A non-invasive tool to detect intestinal swelling and monitor treatment response.

Endoscopic Procedures

Endoscopy allows for direct visualization and biopsy collection, which is critical for confirming Crohn’s disease.

  • Colonoscopy: The gold standard for diagnosing colonic and ileal Crohn’s disease.
  • Capsule Endoscopy: A pill-sized camera captures images of the small intestine, which is useful for detecting Crohn’s disease beyond the reach of a colonoscopy.
  • Upper Endoscopy (EGD): Used if symptoms suggest esophageal, stomach, or duodenal involvement.

Differential Diagnosis

Distinguishing Crohn’s from Other IBDs

  • Crohn’s vs. Ulcerative Colitis (UC): Unlike UC, which only affects the colon, Crohn’s can involve the entire GI tract and cause deeper tissue damage.
  • Crohn’s vs. Microscopic Colitis: Microscopic colitis causes chronic diarrhea but lacks visible lesions on colonoscopy.

Several conditions mimic Crohn’s disease, including:

  • Celiac Disease: Gluten intolerance that can cause chronic diarrhea and malabsorption.
  • Bacterial or Parasitic Infections: Such as tuberculosis or Clostridium difficile, which can trigger inflammation.
  • Irritable Bowel Syndrome (IBS): A non-inflammatory condition that can cause abdominal pain and diarrhea but lacks tissue damage seen in Crohn’s.

Treatment Options for Crohn's Disease

Treatment for Crohn’s disease focuses on reducing inflammation, managing symptoms, preventing complications, and maintaining remission. 

Conventional Treatments

Medications

The choice of medication depends on disease severity, location, and patient response:

  • Aminosalicylates (5-ASA, e.g., Mesalamine): Used for mild Crohn’s, though more effective in ulcerative colitis.
  • Corticosteroids (Prednisone, Budesonide): Used for short-term symptom control during flare-ups but not recommended for long-term use due to side effects.
  • Immunosuppressants (Azathioprine, Methotrexate, 6-MP): Used for moderate-to-severe Crohn’s to reduce immune system overactivity.
  • Biologic Therapies (TNF inhibitors, IL-12/IL-23 inhibitors): Target specific immune pathways to reduce inflammation and prevent disease progression. Examples include:
    • Infliximab (Remicade) and Adalimumab (Humira): TNF inhibitors effective in severe cases.
    • Ustekinumab (Stelara): IL-12/IL-23 inhibitor for patients who fail other therapies.
    • Vedolizumab (Entyvio): A gut-specific biologic reducing immune cell migration into the intestines.

Surgical Interventions

A majority of Crohn’s patients will need bowel surgery at some point, usually due to strictures, fistulas, or medication failure. 

  • Bowel Resection: Removal of damaged segments of the intestine. While effective, Crohn’s can recur in the remaining areas.
  • Strictureplasty: Widening of narrowed intestinal segments without removing sections.
  • Fistula Repair: Closure of abnormal connections between organs, which can result from prolonged inflammation.

Integrative and Alternative Approaches

Alongside conventional medical treatment, integrative approaches may help manage flares and symptoms.  

  • Exclusive Enteral Nutrition (EEN): A liquid diet used in pediatric patients to induce Crohn’s remission without steroids.
  • Anti-Inflammatory Diets: Diets such as the Mediterranean Diet and the Specific Carbohydrate Diet (SCD) may reduce inflammation and improve symptoms.
  • Acupuncture and Herbal Remedies: Some studies have shown symptom relief, but limited supporting research exists.  

Living with Crohn's Disease

Living with Crohn's disease requires ongoing symptom management, lifestyle modifications, and emotional resilience.

Daily Management and Lifestyle Adjustments

Diet and Nutrition

  • Identifying trigger foods is crucial, as certain foods can worsen symptoms. High-fiber, fatty, or spicy foods may aggravate flares.
  • An anti-inflammatory diet rich in lean proteins, well-cooked vegetables, and omega-3 fatty acids may help reduce inflammation.
  • Hydration is key, especially for those experiencing frequent diarrhea, to prevent dehydration and nutrient deficiencies.
  • Specialized diets, such as the Specific Carbohydrate Diet (SCD) and Mediterranean Diet, are being explored for their role in symptom relief.

Exercise and Physical Activity

  • Regular exercise is linked to better gut motility and overall well-being.
  • Low-impact exercises like yoga, swimming, and walking can help reduce stress and inflammation.
  • Strength training may help counteract muscle loss caused by corticosteroids or nutrient malabsorption.

Mental Health and Emotional Well-being

Coping Strategies

  • Stress is a known trigger for Crohn’s, making stress management techniques like meditation, deep breathing, and biofeedback essential.
  • Cognitive behavioral therapy (CBT) can help individuals cope with anxiety and depression related to chronic illness.
  • Journaling symptoms and tracking diet and stress levels can help identify personal triggers.

Support Systems and Resources

  • Support groups and online communities, such as the Crohn’s & Colitis Foundation, provide education, encouragement, and shared experiences.
  • Mental health professionals who specialize in chronic illness can offer coping strategies for the emotional burden of Crohn’s disease.
  • Workplace accommodations, such as flexible schedules and restroom access, can improve daily living for those managing unpredictable symptoms.

Since Crohn’s disease is progressive, ongoing medical follow-ups are necessary. Regular screenings for complications such as strictures, malnutrition, and colorectal cancer help prevent severe outcomes. 

Emerging Treatments and Research

While there is no cure for Crohn’s disease, ongoing research in genetics, microbiome health, and targeted therapies is reshaping disease management. The future of treatment is moving toward personalized medicine, advanced biologics, and regenerative therapies.

Biologic and Small-Molecule Therapies

  • New IL-12 and IL-23 inhibitors are showing promise for patients who do not respond to traditional treatments.
  • JAK inhibitors and other small-molecule drugs provide alternative options for those resistant to standard biologic therapies.

Personalized and Regenerative Medicine

  • Microbiome-based therapies, including fecal microbiota transplantation (FMT), are being studied to help restore gut bacteria balance.
  • Stem cell therapy is emerging as a potential approach to repairing damaged intestinal tissue and reducing inflammation.

[signup]

Key Takeaways

  • Crohn’s disease is a chronic inflammatory bowel disease (IBD) that can affect any part of the digestive tract, leading to symptoms such as diarrhea, abdominal pain, weight loss, and fatigue.
  • The exact cause of Crohn’s remains unknown, but it is believed to result from a combination of genetic predisposition, environmental factors (such as diet and smoking), and immune system dysfunction.
  • Diagnosis requires multiple tests, including clinical evaluation, blood work, imaging studies (MRI, CT scans), and endoscopic procedures (colonoscopy, capsule endoscopy) to assess disease location and severity.
  • Treatment is individualized and often includes a combination of anti-inflammatory medications, immunosuppressants, biologic therapies (TNF inhibitors, IL-12/IL-23 blockers), and in some cases, surgery to manage symptoms and prevent complications.
  • Lifestyle and dietary modifications play a crucial role in managing Crohn’s. Identifying trigger foods, maintaining a nutrient-rich diet, and managing stress levels can help reduce flare-ups and improve overall well-being.
  • Surgery is sometimes necessary, particularly for patients with strictures, fistulas, or medication-resistant disease, but it does not cure Crohn’s—ongoing management is required.
  • Emerging treatments, including microbiome-based therapies, stem cell research, and personalized medicine, are being explored to develop more effective and targeted treatment strategies.
  • Crohn’s disease is a lifelong condition, but with early diagnosis, proper medical care, and proactive symptom management, many patients can achieve long-term remission and maintain a good quality of life.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Adamji, M., & Day, A. S. (2019). An overview of the role of exclusive enteral nutrition for complicated Crohn’s disease. Intestinal Research, 17(2), 171–176. https://doi.org/10.5217/ir.2018.00079

American Psychological Association. (2017). What Is Cognitive Behavioral Therapy? American Psychological Association. https://www.apa.org/ptsd-guideline/patients-and-families/cognitive-behavioral

Blake, K. (2023, May 22). Anti Inflammatory Diet 101: What to Eat and Avoid Plus Specialty Labs To Monitor Results. Rupa Health. https://www.rupahealth.com/post/anti-inflammatory-diet

Bryant, A. (2024a, August 23). Chronic Clostridioides Difficile (C. diff): Understanding Symptoms, Treatment, and Long-Term Effects. Rupa Health. https://www.rupahealth.com/post/chronic-clostridioides-difficile-c-diff-understanding-symptoms-treatment-and-long-term-effects

Bryant, A. (2024b, September 24). Symptoms of rheumatoid arthritis: Recognizing the early signs. Rupa Health. https://www.rupahealth.com/post/symptoms-of-rheumatoid-arthritis-recognizing-the-early-signs

Cao, J., Yu, Q., Sun, M., He, M., Liu, R., Liu, W., Wang, F., & Li, T. (2022). Acupuncture for Crohn’s disease: protocol for a systematic review and meta-analysis of randomized clinical trials. Medicine, 101(48), e32163. https://doi.org/10.1097/md.0000000000032163

Cleveland Clinic. (2023, July 12). Endoscopy: Procedure, Types, What To Expect. Cleveland Clinic. https://my.clevelandclinic.org/health/diagnostics/25126-endoscopy

Cloyd, J. (2023a, March 29). An Integrative Medicine Guide to Ulcerative Colitis. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-guide-to-ulcerative-colitis

Cloyd, J. (2023b, December 1). How to Interpret CBC Results: A Comprehensive Guide. Rupa Health. https://www.rupahealth.com/post/how-to-interpret-cbc-results-a-comprehensive-guide

Cloyd, J. (2024, January 22). Interpreting Liver Enzyme Tests: ALT, AST, and ALP in Liver Health Monitoring. Rupa Health. https://www.rupahealth.com/post/interpreting-liver-enzyme-tests-alt-ast-and-alp-in-liver-health-monitoring

Crohn's & Colitis Foundation. (n.d.). Medication Options for Crohn’s Disease. Crohn’s & Colitis Foundation. https://www.crohnscolitisfoundation.org/patientsandcaregivers/what-is-crohns-disease/treatment/medication

Crohn's And Colitis Foundation. (2019). Crohn’s & Colitis Foundation. Crohnscolitisfoundation.org. https://www.crohnscolitisfoundation.org/

Crohn's and Colitis Foundation. (n.d.). Fact Sheet. https://www.crohnscolitisfoundation.org/sites/default/files/legacy/assets/pdfs/jak-inhibitors.pdf

Dave, M., Dev, A., Somoza, R. A., Zhao, N., Viswanath, S., Mina, P. R., Chirra, P., Obmann, V. C., Mahabeleshwar, G. H., Menghini, P., Durbin-Johnson, B., Nolta, J., Soto, C., Osme, A., Khuat, L. T., Murphy, W. J., Caplan, A. I., & Cominelli, F. (2024). MSCs mediate long-term efficacy in a Crohn’s disease model by sustained anti-inflammatory macrophage programming via efferocytosis. Npj Regenerative Medicine, 9(1), 1–16. https://doi.org/10.1038/s41536-024-00347-1

DePorto, T. (2023a, January 26). Using the Specific Carbohydrate Diet for IBD Symptom Relief. Rupa Health. https://www.rupahealth.com/post/using-the-specific-carbohydrate-diet-for-ibd-symptom-relief

DePorto, T. (2023b, February 1). The Gut’s Role in The Development and Treatment of Psoriasis: A Integrative Medicine Approach. Rupa Health. https://www.rupahealth.com/post/the-guts-role-in-the-development-and-treatment-of-psoriasis-a-integrative-medicine-approach

Fehily, S. R., Basnayake, C., Wright, E. K., & Kamm, M. A. (2021). Fecal microbiota transplantation therapy in Crohn’s disease: Systematic review. Journal of Gastroenterology and Hepatology, 36(10), 2672–2686. https://doi.org/10.1111/jgh.15598

Ganga, W., Chubb, S. P., Gillett, M. J., & Vasikaran, S. D. (2018). Faecal Calprotectin. The Clinical Biochemist Reviews, 39(3), 77. https://pmc.ncbi.nlm.nih.gov/articles/PMC6370282/

Kresge, K. (2022, October 31). IBS vs IBD: Know the symptoms. Rupa Health. https://www.rupahealth.com/post/ibs-vs-ibd-know-the-symptoms

Lewis, R. T., & Maron, D. J. (2010). Efficacy and Complications of Surgery for Crohn’s Disease. Gastroenterology & Hepatology, 6(9), 587. https://pmc.ncbi.nlm.nih.gov/articles/PMC2976865/

Malani, S. (2023, February 22). Inflammatory Markers 101: How To Interpret. Rupa Health. https://www.rupahealth.com/post/inflammatory-markers-101-what-do-they-mean

Massey, D., & Parkes, M. (2007). Common pathways in Crohn’s disease and other inflammatory diseases revealed by genomics. Gut, 56(11), 1489–1492. https://doi.org/10.1136/gut.2007.127928

Moy, M. P., Sauk, J., & Gee, M. S. (2016). The Role of MR Enterography in Assessing Crohn’s Disease Activity and Treatment Response. Gastroenterology Research and Practice, 2016, 1–13. https://doi.org/10.1155/2016/8168695

Nemati, R., Mehdizadeh, S., Salimipour, H., Yaghoubi, E., Alipour, Z., Tabib, S. M., & Assadi, M. (2017). Neurological manifestations related to Crohn’s disease: a boon for the workforce. Gastroenterology Report, 7(4), 291–297. https://doi.org/10.1093/gastro/gox034

NIH. (n.d.). Microscopic Colitis | NIDDK. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/digestive-diseases/microscopic-colitis

NYU Langone Health. (n.d.). Norovirus Link to Crohn’s Disease May Point to New Therapies. NYU Langone News. https://nyulangone.org/news/norovirus-link-crohns-disease-may-point-new-therapies

Ranasinghe, I., Hsu, R., & Tian, C. (2024, February 24). Crohn Disease. PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK436021/

Weinberg, J. (2022a, February 28). An Integrative Medicine Approach to Celiac Disease. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-celiac-disease

Weinberg, J. (2022b, April 14). 4 lifestyle changes that help manage crohn’s disease. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-crohns-disease

Weinberg, J. (2022c, November 16). 4 Science Backed Health Benefits of The Mediterranean Diet. Rupa Health. https://www.rupahealth.com/post/4-science-backed-health-benefits-of-the-mediterranean-diet

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on GI Health
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.

Hey practitioners! 👋 Join Dr. Robert Silverman for an insightful webinar, "Food Sensitivities, GLP-1, and Gut Health" on April 2nd at 2 PM EST / 11 AM PST. In this session, you'll gain insight into how GLP-1 may play a role in gut function, metabolism, and immune response, how food sensitivities may be linked to digestive discomfort, and practical strategies to help support gut health and overall well-being. Register now to secure your spot!